IDEAL: IDENTIFICATION AND CHARACTERISATION OF NEW THERAPEUTIC APPROACHES AGAINST CANCER (Q2023975): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 06:12, 2 November 2020
Project Q2023975 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IDEAL: IDENTIFICATION AND CHARACTERISATION OF NEW THERAPEUTIC APPROACHES AGAINST CANCER |
Project Q2023975 in Italy |
Statements
781,317.04 Euro
0 references
1,041,756.09 Euro
0 references
75.0 percent
0 references
31 October 2018
0 references
30 April 2020
0 references
UNIVERSITA' DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI
0 references
BIOGEM IRGS ISTITUTO DI RICERCHE GENETICHE
0 references
BIOPULSE S.R.L.
0 references
EPI-C S.R.L.
0 references
PENTA TECHNOLOGY S.R.L.
0 references
40°50'9.35"N, 14°14'55.61"E
0 references
IDEAL INTENDE REALIZZARE UNA NUOVA SOLUZIONE TECNOLOGICA: UN NUOVO PRODOTTO (MOLECOLA ANTICANCRO SU BASE EPIGENETICA), UN NUOVO METODO DI DELIVERY (BASATO SULLA ELETTROPORAZIONE IN VIVO), UN SISTEMA DI INTEGRAZIONE DI DATI MOLECOLARI DI IMAGING UTILE PER LA PREVISIONE DELLA RISPOSTA A TRATTAMENTO E DUNQUE STRATIFICAZIONE PAZIENTI FINO ALL'AVANZATA FASE PRECLINICA. (Italian)
0 references
IDEAL INTENDS TO CREATE A NEW TECHNOLOGICAL SOLUTION: A NEW PRODUCT (EPIGCRO CANCER ON AN EPIGO-GENETIC BASIS), A NEW DELIVERY METHOD (BASED ON IN VIVO ELECTROPORATION), A SYSTEM OF INTEGRATION OF MOLECULAR DATA OF IMAGING USEFUL FOR PREDICTING TREATMENT RESPONSE, AND THUS THE STRATIFICATION OF PATIENTS UP TO THE ADVANCED PRE-CLINICAL PHASE. (English)
0 references
Identifiers
B63D18000560007
0 references